American National Bank & Trust (Virginia)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
IC
American National Bank & Trust (Virginia)'s NVS Position: Q4 2015 in Review
American National Bank & Trust (Virginia) increased its Novartis (NVS) stake by 0.59% in Q4 2015, buying an estimated $4.61K and bringing the position to 9,903 shares worth $763K. The position accounts for 0.36% of the portfolio, ranked #75.
American National Bank & Trust (Virginia) first reported a position in NVS in Q2 2014 and has held it in 7 quarters since. The position peaked at $875K in Q2 2015. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.
- American National Bank & Trust (Virginia) held 9,903 shares of Novartis worth $763K as of Q4 2015.
- American National Bank & Trust (Virginia) bought 58 Novartis shares in Q4 2015, an estimated $4.61K.
- Novartis made up 0.36% of American National Bank & Trust (Virginia)'s portfolio in Q4 2015, its #75 holding.
- American National Bank & Trust (Virginia) first reported a position in Novartis in Q2 2014 and has held it in 7 quarters since.
- American National Bank & Trust (Virginia)'s Novartis position peaked at $875K in Q2 2015.
- 927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.
Based on American National Bank & Trust (Virginia)'s 13F filing for Q4 2015, filed 9 Feb 2016.